OFIX — Orthofix Medical Share Price
0.000.00%
Last trade - 00:00- $553.73m
- $646.10m
- $799.49m
- 65
- 69
- 89
- 88
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 53.35 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.1 | ||
| Price to Tang. Book | 2.64 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.69 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -11.68% | ||
| Return on Equity | -22.87% | ||
| Operating Margin | -10.58% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 406.56 | 464.48 | 460.71 | 746.64 | 799.49 | 821.98 | 874.63 | 11.69% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | +270.63 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Orthofix Medical Inc. is a global medical technology company. The Company offers a portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH navigation system. The Company’s Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. The segment provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Orthopedics segment offers products and solutions for limb deformity correction and complex limb reconstruction with a focus on use in trauma, adult and pediatric limb reconstruction, and foot and ankle procedures.
Directors
- Jon Serbousek PRE (60)
- Douglas Rice CFO (55)
- Paul Gonsalves CEX (55)
- Kevin Kenny CEX (56)
- Kimberley Elting OTH (56)
- Wayne Burris DRC
- Thomas West DRC (57)
- Jason Hannon IND (49)
- James Hinrichs IND (53)
- Lilly Marks IND (73)
- Michael Paolucci IND (61)
- John Sicard IND (58)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 31st, 2018
- Public Since
- April 24th, 1992
- No. of Shareholders
- 428
- No. of Employees
- 1,616
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 39,022,492
- Address
- 3451 Plano Pkwy, LEWISVILLE, 75056-9453
- Web
- https://ir.orthofix.com/ir-home/default.aspx
- Phone
- +1 2149372000
- Contact
- Julie Dewey
- Auditors
- Ernst & Young LLP
Upcoming Events for OFIX
Q1 2025 Orthofix Medical Inc Earnings Release
Q2 2025 Orthofix Medical Inc Earnings Release
Similar to OFIX
10X Genomics
NASDAQ Global Select Market
Accuray
NASDAQ Global Select Market
Akoya Biosciences
NASDAQ Global Select Market
Align Technology
NASDAQ Global Select Market
Alphatec Holdings
NASDAQ Global Select Market
FAQ
What is the Orthofix Medical share price?
As of Today at 22:31 UTC, shares in Orthofix Medical are trading at $14.19. This share price information is delayed by 15 minutes.
How has the Orthofix Medical share price performed this year?
Shares in Orthofix Medical last closed at $14.19 and the price had moved by +8.32% over the past 365 days. In terms of relative price strength the Orthofix Medical share price has underperformed the S&P500 Index by -0.02% over the past year.
What are the analyst and broker recommendations for Orthofix Medical?
The overall consensus recommendation for Orthofix Medical is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Orthofix Medical dividend yield?
Orthofix Medical does not currently pay a dividend.
Does Orthofix Medical pay a dividend?
Orthofix Medical does not currently pay a dividend.
When does Orthofix Medical next pay dividends?
Orthofix Medical does not currently pay a dividend.
How do I buy Orthofix Medical shares?
To buy shares in Orthofix Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Orthofix Medical?
As of the previous close price of $14.19, shares in Orthofix Medical had a market capitalisation of $553.73m.
Where are Orthofix Medical shares listed?
Here are the trading details for Orthofix Medical:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: OFIX
What kind of share is Orthofix Medical?
Based on an overall assessment of its quality, value and momentum Orthofix Medical is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Orthofix Medical share price forecast for 2025?
The analyst consensus target price for shares in Orthofix Medical is $24.30. That is 71.25% above the last closing price of $14.19.
Analysts covering Orthofix Medical currently have a consensus Earnings Per Share (EPS) forecast of $0.14 for the next financial year.
Find out moreWhat is the trend in the Orthofix Medical share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Orthofix Medical. Over the past six months, its share price has underperformed the S&P500 Index by -5.82%.
As of the last closing price of $14.19, shares in Orthofix Medical were trading -15.61% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Orthofix Medical PE Ratio?
The Orthofix Medical PE ratio based on its reported earnings over the past 12 months is 53.35. The shares last closed at $14.19.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Orthofix Medical?
Orthofix Medical's management team is headed by:
- Jon Serbousek - PRE
- Douglas Rice - CFO
- Paul Gonsalves - CEX
- Kevin Kenny - CEX
- Kimberley Elting - OTH
- Wayne Burris - DRC
- Thomas West - DRC
- Jason Hannon - IND
- James Hinrichs - IND
- Lilly Marks - IND
- Michael Paolucci - IND
- John Sicard - IND